flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Semaglutides Are Poised to Remake Chronic Kidney Disease Care 🚨 Journal Club: FLOW Trial

Mechanistically, GHK-Cu appears to act through several pathways: Collagen and elastin remodeling: Gene array work by Finkley et al., reported in the second edition of Cosmeceuticals and Active Cosmetics (Taylor and Francis, 2005), examined GHK-Cu effects on human fibroblast cultures across a nanomolar to low micromolar concentration range and found upregulation of decorin, collagen, and elastin-associated genes

We recommend a consultation with one of our licensed practitioners to confirm suitability

therefore, current interpretations draw on evidence from obesity, aging, and caloric restriction literature

Think of it as part of the therapy

Daily SPF is non-negotiable, since unprotected sun exposure can deepen the same pigmentation kojic acid is working to fade